AVEO Oncology
AVEO
#7488
Rank
HK$4.09 B
Marketcap
HK$117.70
Share price
0.00%
Change (1 day)
173.01%
Change (1 year)

AVEO Oncology (AVEO) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : HK$0.56 Billion

According to AVEO Oncology 's latest financial reports the company's total liabilities are HK$0.56 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AVEO Oncology - Total liabilities on balance sheet (from 2008 to 2022)

Total liabilities by year

Year Total liabilities Change
2021-12-31HK$0.46 B89.19%
2020-12-31HK$0.24 B-11.98%
2019-12-31HK$0.27 B-35.54%
2018-12-31HK$0.43 B-39.22%
2017-12-31HK$0.71 B213.77%
2016-12-31HK$0.22 B25.34%
2015-12-31HK$0.18 B-53.46%
2014-12-31HK$0.38 B-34.47%
2013-12-31HK$0.59 B-13.66%
2012-12-31HK$0.68 B23.55%
2011-12-31HK$0.55 B-9.98%
2010-12-31HK$0.61 B10.56%
2009-12-31HK$0.55 B-57.21%
2008-12-31HK$1.30 B0.7%
2007-12-31HK$1.29 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eli Lilly
LLY
HK$850.63 B 149,654.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$658.75 B 115,873.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$103.88 B 18,188.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$78.61 B 13,740.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$512.52 B 90,129.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
HK$0.17 B-68.68%๐Ÿ‡บ๐Ÿ‡ธ USA